Dr. Steven M Kernerman , DO
Allergy & Immunology • Spokane, WA
1330 N Washington St Ste 4200
Spokane, WA 992012476
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Steven Kernerman is listed in NPPES under Allergy & Immunology.
-
NPI assigned on October 31, 2005; this date does not establish years in practice.
-
Published CMS data list 5,376 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J2357 — Injection, omalizumab, 5 mg: 3,075 service units.
- 95165 — Professional service for preparation and provision of 1 or more antigens: 809 service units.
- 95004 — Test for allergy using allergenic extract: 738 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 11 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 1,101 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Montelukast Sodium — 298 prescription fills, including refills.
- Albuterol Sulfate Hfa (Albuterol Sulfate) — 109 prescription fills, including refills.
- Ipratropium Bromide — 82 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 27 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 60% of clinicians listed under Allergy & Immunology in Washington (2024, 43 clinicians with data). Median for this group: 3,583. Middle half: 640 to 6,145.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 4,715 in 2020 to 5,376 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
1330 N Washington St Ste 4200
Spokane, WA 992012476
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Inland Allergy And Asthma Associates Ps. See the list
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
1986
What Public CMS Data Show
Allergy & Immunology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
225 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $157,558 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $123,712 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
1,589 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$998,506 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,191.07 across 51 records.
By nature of payment
- Food and Beverage: $1,165.17 across 50 records.
- Consulting Fee: $25.90 across 1 record.
Reporting-company totals (3 largest of 18)
- AstraZeneca Pharmaceuticals LP: $212.54 across 11 records.
- Sanofi and Genzyme US Companies: $157.55 across 7 records.
- Novartis Pharmaceuticals Corporation: $73.47 across 4 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
40 years (graduated 1986)
CMS Doctors and Clinicians data list 1986 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
NPI first issued
2005
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Dr. Kernerman has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Kernerman as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Spokane and Washington
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 60% of clinicians listed under Allergy & Immunology in Washington (2024, 43 clinicians with data). Median for this group: 3,583. Middle half: 640 to 6,145.
Too few clinicians listed under Allergy & Immunology in Spokane have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A higher Medicare-allowed amount than 70% of clinicians listed under Allergy & Immunology in Washington (2024, 43 clinicians with data). Median for this group: $83,941. Middle half: $18,813 to $178,732.
Too few clinicians listed under Allergy & Immunology in Spokane have Medicare Part B data for 2024 to compare.
Paid by Medicare
A higher Medicare payment amount than 70% of clinicians listed under Allergy & Immunology in Washington (2024, 43 clinicians with data). Median for this group: $58,355. Middle half: $13,666 to $140,163.
Too few clinicians listed under Allergy & Immunology in Spokane have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 90% of clinicians listed under Allergy & Immunology in Washington (2024, 50 clinicians with data). Median for this group: 392. Middle half: 237 to 631.
Too few clinicians listed under Allergy & Immunology in Spokane have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Allergy & Immunology in Washington (2024, 50 clinicians with data). Median for this group: $121,403. Middle half: $47,321 to $300,501.
Too few clinicians listed under Allergy & Immunology in Spokane have Medicare Part D data for 2024 to compare.
6 active clinicians are listed under Allergy & Immunology with a practice address in Spokane, WA (90 in Washington).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 14% from 4,715 in 2020 to 5,376 in 2024.
- 2020: 4,715
- 2021: 10,859
- 2022: 9,278
- 2023: 7,019
- 2024: 5,376
-
Medicare-allowed amount
Medicare-allowed amount increased 116% from $72,791 in 2020 to $157,558 in 2024.
- 2020: $72,791
- 2021: $289,666
- 2022: $257,314
- 2023: $203,781
- 2024: $157,558
-
Paid by Medicare
Paid by Medicare increased 131% from $53,474 in 2020 to $123,712 in 2024.
- 2020: $53,474
- 2021: $226,891
- 2022: $199,392
- 2023: $158,031
- 2024: $123,712
-
Medicare Part D prescriptions
Medicare Part D prescriptions stayed about the same: 1,094 in 2020 and 1,101 in 2024.
- 2020: 1,094
- 2021: 1,097
- 2022: 1,092
- 2023: 1,039
- 2024: 1,101
-
30-day fills
30-day fills stayed about the same: 1,601 in 2020 and 1,589 in 2024.
- 2020: 1,601
- 2021: 1,665
- 2022: 1,585
- 2023: 1,527
- 2024: 1,589
-
Part D drug cost
Part D drug cost increased 17% from $857,083 in 2020 to $998,506 in 2024.
- 2020: $857,083
- 2021: $1,150,529
- 2022: $455,388
- 2023: $462,232
- 2024: $998,506
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $233.49 in 2021 to $1,191.07 in 2025.
- 2021: $233.49
- 2022: $350.55
- 2023: $749.42
- 2024: $746.67
- 2025: $1,191.07
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 51 records totaling $1,191.07.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
AYVAKIT | General | $43.82 |
| Blueprint Medicines Corporation |
Food and Beverage
Cash or cash equivalent
|
AYVAKIT | General | $41.30 |
| TerSera Therapeutics LLC |
Food and Beverage
In-kind items and services
|
Quzyttir | General | $39.18 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $36.50 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
OCTAGAM IMMUNE GLOBULIN (HUMAN) | General | $35.36 |
| BioCryst Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
ORLADEYO | General | $32.88 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Food and Beverage
In-kind items and services
|
GLASSIA | General | $32.54 |
| Blueprint Medicines Corporation |
Food and Beverage
Cash or cash equivalent
|
AYVAKIT | General | $31.99 |
| Pharming Healthcare, Inc. |
Food and Beverage
In-kind items and services
|
RUCONEST | General | $31.95 |
| Octapharma USA, Inc. |
Food and Beverage
In-kind items and services
|
OCTAGAM IMMUNE GLOBULIN (HUMAN) | General | $28.43 |
| CSL Behring |
Food and Beverage
In-kind items and services
|
Andembry | General | $28.27 |
| Grifols Shared Services North America, Inc. |
Food and Beverage
In-kind items and services
|
Xembify | General | $27.00 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $26.27 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
OCTAGAM IMMUNE GLOBULIN (HUMAN) | General | $25.93 |
| ADMA BioManufacturing LLC |
Consulting Fee
Cash or cash equivalent
|
— | General | $25.90 |
| Octapharma USA, Inc. |
Food and Beverage
In-kind items and services
|
OCTAGAM IMMUNE GLOBULIN (HUMAN) | General | $25.10 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
TEZSPIRE | General | $24.66 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
TEZSPIRE | General | $24.53 |
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
OPZELURA | General | $23.94 |
| CSL Behring |
Food and Beverage
In-kind items and services
|
Hizentra | General | $23.66 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
NUCALA | General | $23.55 |
| Pharming Healthcare, Inc. |
Food and Beverage
In-kind items and services
|
RUCONEST | General | $22.98 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
NUCALA | General | $22.86 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $22.72 |
| Galderma Laboratories, L.P. |
Food and Beverage
In-kind items and services
|
NEMLUVIO | General | $22.24 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J2357
Injection, omalizumab, 5 mg
|
3,075 | 15 | $98.00 | $37.29 |
|
95165
Professional service for preparation and provision of 1 or more antigens
|
809 | 39 | $40.00 | $14.55 |
|
95004
Test for allergy using allergenic extract
|
738 | 15 | $10.00 | $3.65 |
|
95117
Professional service for multiple injections of allergen
|
280 | 87 | $30.00 | $12.46 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
120 | 99 | $322.58 | $126.69 |
|
96372
Injection of drug or substance under skin or into muscle
|
117 | 19 | $40.00 | $14.37 |
|
96160
Administration and interpretation of patient-focused health risk assessment
|
75 | 57 | $10.00 | $3.03 |
|
95115
Professional service for single injection of allergen
|
71 | 31 | $26.00 | $10.48 |
|
94010
Test to measure expiratory airflow and volume
|
52 | 43 | $69.00 | $27.54 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
28 | 28 | $421.00 | $166.11 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
11 | 11 | $229.00 | $90.81 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Montelukast Sodium | Montelukast Sodium | 298 | 14,149 | $3,251.29 | 53 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 109 | 3,005 | $3,968.55 | 50 |
| Ipratropium Bromide | Ipratropium Bromide | 82 | 3,034 | $2,235.10 | 26 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 75 | 3,570 | $14,915.50 | 17 |
| Arnuity Ellipta | Fluticasone Furoate | 43 | 1,620 | $10,515.95 | — |
| Symbicort | Budesonide/Formoterol Fumarate | 42 | 2,220 | $17,174.84 | — |
| Dulera | Mometasone/Formoterol | 39 | 1,771 | $19,761.96 | — |
| Incruse Ellipta | Umeclidinium Bromide | 33 | 1,530 | $16,457.35 | — |
| Prednisone | Prednisone | 29 | 605 | $78.54 | 11 |
| Dupixent Syringe | Dupilumab | 29 | 812 | $113,867.85 | — |
| Zafirlukast | Zafirlukast | 28 | 840 | $1,427.20 | — |
| Breo Ellipta | Fluticasone/Vilanterol | 27 | 1,200 | $15,611.60 | — |
| Spiriva Respimat | Tiotropium Bromide | 27 | 1,350 | $24,810.58 | — |
| Fluticasone Propionate | Fluticasone Propionate | 26 | 1,650 | $631.50 | 14 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 26 | 802 | $14,279.29 | — |
| Azelastine Hcl | Azelastine Hcl | 22 | 1,085 | $809.75 | — |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 22 | 780 | $16,677.80 | — |
| Epinephrine | Epinephrine | 20 | 485 | $4,379.82 | 15 |
| Panzyga | Immun Glob G(Igg)-Ifas/Glycine | 20 | 560 | $106,848.07 | — |
| Ventolin Hfa | Albuterol Sulfate | 17 | 561 | $1,700.35 | — |
| Advair Hfa | Fluticasone Propion/Salmeterol | 16 | 900 | $10,080.88 | — |
| Breyna | Budesonide/Formoterol Fumarate | 13 | 450 | $2,722.46 | — |
| Desloratadine | Desloratadine | 12 | 360 | $313.48 | — |
| Qvar Redihaler | Beclomethasone Dipropionate | 12 | 420 | $4,098.43 | — |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 12 | 1,020 | $2,369.02 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2025-02-04NUCC Taxonomy Code: 207K00000X
An allergist-immunologist is trained in evaluation, physical and laboratory diagnosis, and management of disorders involving the immune system. Selected examples of such conditions include asthma, anaphylaxis, rhinitis, eczema, and adverse reactions to drugs, foods, and insect stings as well as immune deficiency diseases (both acquired and congenital), defects in host defense, and problems related to autoimmune disease, organ transplantation, or malignancies of the immune system.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - ALLERGY/IMMUNOLOGY
I20100927001218
WA
1951349398
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Inland Allergy And Asthma Associates Ps
1330 N Washington St, Spokane, WA 992012476
Phone: 5097471624
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Physician Assistant
Physician Assistant
Nurse Practitioner - Family
Advanced Registered Nurse Practitioner
Allergy & Immunology
Doctor of Osteopathic Medicine (D.O.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 1330 N WASHINGTON ST STE 4200, SPOKANE, WA 992012476 (Tel: 5097471624)
Registered at 1330 N WASHINGTON ST STE 4200, SPOKANE, WA 992012476 (Tel: 5097471624)
NPI status registered as active in NPPES database
Registered at 508 W 6TH AVE, SUITE 700, SPOKANE, WA 992042770 (Tel: 5097471624)
Registered at 508 W 6TH AVE, SUITE 700, SPOKANE, WA 992042770 (Tel: 5097471624)
Recorded as STEVEN KERNERMAN, D.O.
Allergy & Immunology (license number reported to NPPES: WA OP00001363)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Allergy & Immunology Specialists in Spokane
Healthcare providers in SpokaneMailing Address
1330 N Washington St Ste 4200
Spokane, WA 992012476
Phone: 5097471624